Resources

Respiratory syncytial virus (RSV) is a major, under–recognized public health problem causing more severe respiratory infections and hospitalizations in infants and young children each year than any other pathogen. New immunization tools now recommended for global use by the World Health Organization (WHO) could help change that.The opportunity to address this pervasive virus has never been better. To raise awareness, WHO and PATH have developed a toolkit of communication materials that public health stakeholders and advocates can use to share information about RSV disease, new prevention tools, and delivery considerations. Other expert contributors include the US Centers for Disease Control and Prevention, Seattle Children's Hospital/University of Washington, UMC Utrecht, the International Vaccine Access Center (IVAC), RRD Design, and more.To accommodate varying audience and engagement needs, this toolkit includes a stand-alone RSV primer presentation (and fact sheet) providing an overview of RSV disease and prevention options. Also available are modular PowerPoint slides that can be mixed and matched with the primer presentation to dive deeper into key topics for informing understanding and decision-making around RSV prevention. All slides come with speaker notes.To learn more about the toolkit, visit the web page.NOTE: Files available here as read-only. Editable files are readily available upon request. Please contact us.

The Strengthening Newborn Nutrition and Essential Health care Interventions in Nepal (SNEHI-N) project is transforming newborn care by making human milk more accessible to vulnerable babies. Implemented by PATH in collaboration with Nepal’s Ministry of Health and Population, the project has established human milk banks - Comprehensive Lactation Management Centers (CLMCs) and Lactation Management Units (LMUs) to ensure safe donor human milk reaches infants in need. Through breastfeeding support, lactation counseling, and neonatal care, SNEHI-N is improving newborn nutrition, empowering mothers, strengthening health care systems, and reducing infant mortality.

In 2024, PATH, supported by the Johnson & Johnson Foundation (J&J), disseminated learnings from youth-focused, digital-first TB initiatives in India and Indonesia, highlighting best practices for implementers, funders, and government TB programs.In India, the #BeTheChange campaign under the Corporate TB Pledge reached 5.5 crore (55 million) youth, demonstrating the power of digital media in activating youth for volunteering and behavior change. The campaign received positive feedback, with calls for sustainable scale-up. Additionally, PATH developed a framework to support the Central TB Division in engaging youth volunteers in TB-free activities, building on findings from a prior campaign where one-third of respondents expressed interest in volunteering, successfully recruiting 36,000 youth across eight cities, reinforcing the role of digital engagement and youth activation in advancing TB elimination efforts.In Indonesia, PATH disseminated best practices from J&J-supported projects addressing TB case-finding challenges. Project Insight surveyed 400 individuals, identifying the “Family first” approach as key to TB care-seeking behaviors. Project TB Warriors, a youth health promotion campaign, reached 3 million people, engaging 50%, with 80,000 undertaking health care actions, 18,000 using online symptom self-screening, and 6,000 fully equipped as “agents of change.” Project Chatbot facilitated TB contact screening via a mobile platform, onboarding 119 index patients and screening 158 contacts, with 93% finding it helpful. These initiatives highlight the impact of community-centered approaches and digital solutions in strengthening TB control efforts.

This six-minute video provides a brief tutorial on how to use PATH’s Vaccine Cost Calculators for middle-income countries. These Excel-based tools are available in English, French, and Spanish and offer an easy way to compare the costs of certain vaccination programs with each vaccine product available in the global market.For middle-income countries, we currently offer calculators for pneumococcal conjugate vaccines and rotavirus vaccines. These tools allow country-level decision-makers and implementers, as well as technical assistance partners, to input local data and then compare estimated vaccination program costs for different vaccine products and presentations, exploring multiple vaccine options at once. The calculators enable users to compare the estimated cold chain volume and financial costs of different vaccination programs annually and for a total period of five years. Users also can add domestically produced vaccine options that are not available in the global market, as well as compare costs for up to three different scenarios of multi-vaccine use for countries that plan to use more than one product at the same time.

The primer provides the data, messages, and resources to help understand the planning, policies, and technologies involved in oxygen delivery scale-up. The materials are useful to anyone who wants to learn about scaling up access to oxygen and integrating oxygen delivery across national and subnational policies, programs, and health budgets.This primer was originally published in 2017, with an updated version in 2025.